VTRS - Viatris and Ocuphire Pharma announces FDA approval for their eye drop formulation
2023-09-27 09:22:17 ET
More on Ocuphire Pharma, Viatris, etc.
- Why 5%-Yielding Viatris Hasn't Doubled Yet
- Viatris Emerges As Challenger In Lucrative Anti-Obesity Drugs Market
- Viatris: Turning Point For Cheap Pharma Stock
- Viatris in talks to sell European OTC assets to CVC unit - report
- Viatris wins tentative FDA approval for HIV therapy in children
For further details see:
Viatris and Ocuphire Pharma announces FDA approval for their eye drop formulation